TuHURA Biosciences, Inc.
HURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001498382
No open-market purchases or sales by TuHURA Biosciences, Inc. insiders were filed in the last 90 days; 89 institutions reported holding it in 13F filings for Q2 2026, worth $21.0M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding TuHURA Biosciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 25 | 22 | −3 |
| Shares | 3.47M | 3.49M | +28.2K (+0.8%) |
| Value | $1.35M | $972.2K | −$376.9K (−27.9%) |
New holders (6)
Institutions that held TuHURA Biosciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Acadian Asset Management LLC | 207,114 | $58.0K | 0.00% |
| LPL Financial LLC | 20,253 | $6.00K | 0.00% |
| Affinity Capital Advisors, LLC | 18,590 | $5.00K | 0.00% |
| Pathstone Family Office, LLC | 10,000 | $2.78K | 0.00% |
| Tucker Asset Management LLC | 1,000 | $278 | 0.00% |
| HighMark Wealth Management LLC | 1,000 | $0 | 0.00% |
Sold out (9)
Institutions that held TuHURA Biosciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| BlackRock Inc. | 91,280 | $36.0K |
| Virtu Financial LLC | 41,292 | $16.0K |
| Raymond James & Associates | 15,740 | $6.00K |
| Eaton Vance Management | 10,000 | $4.00K |
| Koshinski Asset Management, Inc. | 4,000 | $1.59K |
| Prospera Financial Services Inc | 3,078 | $1.00K |
| Lindbrook Capital, LLC | 2,135 | $1.00K |
| FMR LLC | 140 | $0 |
| Citigroup Inc | 500 | $0 |